The 44th Annual William Blair Growth Stock Conference
Logotype for Donaldson Company Inc

Donaldson Company (DCI) The 44th Annual William Blair Growth Stock Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for Donaldson Company Inc

The 44th Annual William Blair Growth Stock Conference summary

1 Feb, 2026

Key messages and strategic direction

  • Emphasizes technology leadership and complex problem-solving in filtration, with a shift from geographic to vertical segment orientation for faster growth.

  • Focus on sustainability, enabling the green economy, and a balanced approach to organic and inorganic growth.

  • Life Sciences identified as a new vertical, with significant recent acquisitions and disruptive technologies.

  • Company has a global presence, with 75% of volume built within regional markets to offset supply chain risks.

  • Record financial performance, including record sales, operating margin, and EPS, with a 10% CAGR over three years.

Technology, innovation, and competitive advantages

  • Over 2,700 patents released from 2019 to 2023, highlighting a strong commitment to R&D and innovation.

  • Proprietary technologies enable solutions like 99% acetonitrile reclamation, supporting customer sustainability goals.

  • Deep customer relationships and diversified product applications, from medical devices to industrial engines.

  • High aftermarket retention, with 65% of business from replacement parts and 60 manufacturing plants worldwide.

  • Leadership in alternative power solutions and fuel cell programs, leveraging cross-segment technology expertise.

Segment growth and market opportunities

  • Mobile Solutions segment focuses on non-passenger vehicle markets, with confidence in long-term growth despite slow alternative power adoption.

  • Industrial segment strategy includes connected solutions, driving double-digit aftermarket growth and data-driven innovation.

  • Life Sciences segment expanded by $21 billion in addressable market through four recent acquisitions, including Medica for hollow fiber membranes.

  • Food and beverage business growing, with bioreactors enabling cultivated meat partnerships and medical device filter leadership.

  • Ongoing R&D in implantable medical devices and advanced filtration materials like expanded Teflon.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more